User contributions
Jump to navigation
Jump to search
- 00:10, 9 January 2020 diff hist -5 Non-small cell lung cancer, ALK-positive →Biomarker Eligibility Criteria
- 00:08, 9 January 2020 diff hist +106 Non-small cell lung cancer, ALK-positive →Regimen {{#subobject:4e0d06|Variant=1}}
- 00:05, 9 January 2020 diff hist +108 Non-small cell lung cancer, ALK-positive →Regimen {{#subobject:9134b2|Variant=1}}
- 00:00, 9 January 2020 diff hist +113 Non-small cell lung cancer, ALK-positive →Regimen {{#subobject:b495b6|Variant=1}}
- 23:54, 8 January 2020 diff hist +108 Non-small cell lung cancer, ALK-positive →Variant #2, 750 mg/day fasting {{#subobject:a93389|Variant=1}}
- 23:52, 8 January 2020 diff hist -14 Non-small cell lung cancer, ALK-positive →Biomarker Eligibility Criteria
- 23:51, 8 January 2020 diff hist +123 Non-small cell lung cancer, ALK-positive →Variant #1, 450 mg/day with food {{#subobject:2ff82e|Variant=1}}
- 23:24, 8 January 2020 diff hist +102 Non-small cell lung cancer, ALK-positive →Advanced or metastatic disease, ALK inhibitor-exposed
- 23:10, 8 January 2020 diff hist +97 Non-small cell lung cancer, ALK-positive →Cisplatin & Pemetrexed {{#subobject:af12b4|Regimen=1}}
- 23:03, 8 January 2020 diff hist +90 Non-small cell lung cancer, ALK-positive →Docetaxel monotherapy {{#subobject:fd1716|Regimen=1}}
- 23:01, 8 January 2020 diff hist +102 Non-small cell lung cancer, ALK-positive →Pemetrexed monotherapy {{#subobject:24ad9b|Regimen=1}}